CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping
- PMID: 25878358
- DOI: 10.1158/1078-0432.CCR-14-2552
CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping
Abstract
In the August 15, 2004, issue of Clinical Cancer Research, Nielsen and colleagues demonstrated how a cancer subtype identified by gene expression profiling could be validated using a widely accessible technology (immunohistochemistry). This opened the door to large-scale studies of archival cohorts and clinical trials, which allowed detailed clinical understanding of a new genomic discovery. Clin Cancer Res; 21(8); 1779-81. ©2015 AACR. See related article by Nielsen et al., Clin Cancer Res 2004;10(16) Aug 15, 2004;5367-74.
©2015 American Association for Cancer Research.
Comment on
-
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res. 2004 Aug 15;10(16):5367-74. doi: 10.1158/1078-0432.CCR-04-0220. Clin Cancer Res. 2004. PMID: 15328174
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical